Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Science from our Sisters

Virginia Hughes  |  Issue: June 2007  |  June 1, 2007

The 982-patient cohort used for both studies was recruited mostly from non-clinical sources—Web sites, newsletters, and lupus support groups—making it much more diverse than if patients were sampled only from academic research centers, says co-author Jinoos Yazdany, MD, MPH, adjunct assistant professor of medicine at the University of California, San Francisco (UCSF). Researchers telephoned each patient to ask detailed questions about their disease history and socioeconomic background—including ethnicity, educational level, income, and medical insurance. The patients were all English speakers and came from 41 different states.

For the first study, researchers focused on how many times patients had seen a rheumatology specialist in the previous year. Patients 65 or older were significantly less likely than younger patients to have seen a specialist at least once (65%, compared to 79% of patients younger than 65); similarly, men were less likely than women to have reported at least one visit (63% versus 79%); as were patients with a household income less than $40,000 (72%, compared to 81% of patients with incomes higher than $40,000).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The seeds of the second study arose at the bedside. While working at the lupus clinic at UCSF, Dr. Yazdany noticed that many of her Medicaid patients were traveling extremely long distances for care. “Some traveled six hours and even had to stay overnight in San Francisco,” she recalls. The patients weren’t making the trek because they wanted to be treated at an academic center, but because rheumatologists closer to home didn’t accept Medicaid. Indeed, the same telephone survey found that patients with only Medicaid insurance traveled an average of 42 miles for care, while patients with private insurance traveled about 24 miles.

These results are especially worrisome if the extra distance means poorer treatment outcomes. “You can imagine that if a patient is traveling six hours in order to see their rheumatologist, if they get sick and don’t have somebody to drive them, they’re not going to make the trip,” she says. “They’ll either have to get care in emergency departments or not get care at all.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Yazdany attributes these demographic and socioeconomic disparities to two major factors: physician awareness and flaws in the U.S. healthcare system. “If the patient’s generalist physician doesn’t have a good understanding of lupus, they may not make a timely and appropriate referral to a specialist,” she says. Moreover, in the last few years, because Medicaid physician reimbursements have dropped significantly, many rheumatologists in private practice say they can no longer afford to accept Medicaid patients. “That’s an example of a national policy that’s directly influencing who’s receiving care,” she laments.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPractice SupportResearch Rheum Tagged with:Arthritis & RheumatologyArthritis Care & ResearchboneglucosamineOsteoarthritispatient careResearchsocioeconomic

Related Articles

    How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

    June 9, 2023

    My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

    Glucosamine Supplements Don’t Help Knee or Hip Arthritis Pain

    August 10, 2017

    (Reuters Health)—Oral glucosamine has no more effect than placebo on joint pain, according to a new meta-analysis. The analysis of randomized controlled trials from which data have been made public found that at both three-month and 24-month follow-up points, the supplement had no effect on either hip or knee pain from arthritis. ad goes here:advert-1ADVERTISEMENTSCROLL…

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

    Osteoarthritis Quo Vadis

    March 1, 2008

    Our knowledge of OA has progressed far—does a cure lie ahead?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences